Latest Regulatory News

Raptis Group Limited has confirmed the resignation of director James Raptis effective September 30, 2025, amid a sharp rise in its share price and trading volume. The company denies any other undisclosed information behind the recent market activity.

MIXI Australia Pty Ltd has initiated an all-cash off-market takeover bid for PointsBet Holdings Limited at $1.20 per share, a significant premium recommended unanimously by the PointsBet Board. The offer promises certainty of cash consideration amid competing bids and regulatory conditions.

MIXI Australia has lodged a bidder’s statement for an all-cash $1.20 per share takeover offer for PointsBet Holdings Limited, with the PointsBet Board unanimously recommending acceptance in the absence of a superior proposal.

Silk Logistics Holdings has scheduled its shareholder meeting for August 1 to vote on the proposed $2.14 per share acquisition by DP World Australia, with an independent expert reaffirming the deal’s fairness.

Scalare Partners Holdings Limited has had its trading suspension lifted following its announcement of a capital raising to fund the acquisition of Tank Stream Labs.

Lumos Diagnostics has locked in a A$5 million secured loan facility to support working capital as it advances toward FDA CLIA waiver for its FebriDx® test, complementing a landmark US distribution deal.

Australian Rare Earths (ASX, AR3) has responded to an ASX price query, denying any undisclosed price-sensitive information and attributing recent trading activity to sector interest and recent company announcements.

Clarity Pharmaceuticals has successfully completed recruitment for its pivotal Co-PSMA Phase II trial, testing its novel Cu-SAR-bisPSMA diagnostic against the current standard in detecting prostate cancer recurrence. This milestone advances their mission to improve early detection and treatment outcomes for men with low PSA levels.

Nova Minerals has closed a US$11.1 million underwritten offering on NASDAQ, positioning itself to advance exploration and feasibility studies at its Estelle Gold and Critical Minerals Project in Alaska.

Locksley Resources has confirmed multiple new mineralised trends at its Mojave Critical Minerals Project in California, setting the stage for an expanded drilling campaign in Q3 2025. The company’s detailed structural mapping and 3D geological modelling have refined exploration targets for antimony and rare earth elements, aligning with growing US strategic interests in domestic critical minerals.

Little Green Pharma reported a robust June 2025 quarter with record cash receipts and expanding European footprint, highlighted by a new production capacity in Denmark and the launch of its CherryCo brand in Germany.

Agrimin Limited's associate, Tali Resources, officially lists on the ASX with Agrimin holding a significant 27% stake following a fully subscribed $2 million priority offer.